AKT and the Hallmarks of Cancer

Area of Science:

• Oncology
• Molecular Biology
• Cell Signaling

Background:

• The "hallmarks of cancer" describe key biological capabilities acquired during tumor development.
• The AKT signaling pathway, activated by receptor tyrosine kinases and PI3K, is crucial for cellular physiology.
• Dysregulation of AKT signaling is frequently observed in tumors and impacts oncogenesis.

Purpose of the Study:

• To review the evidence linking the AKT pathway to the established hallmarks of cancer.
• To discuss the complexities of targeting the AKT pathway for cancer therapy.

Main Methods:

• Literature review of studies investigating AKT signaling in cancer.
• Analysis of the role of AKT in cellular transformation and tumor progression.

Main Results:

• The AKT pathway is implicated in nearly all recognized hallmarks of cancer.
• AKT signaling influences multiple cellular processes critical for oncogenesis.
• Dysregulated AKT activity contributes to diverse pathological ramifications in cancer.

Conclusions:

• The AKT pathway is a central player in the multifaceted nature of human malignant diseases.
• Targeting the AKT pathway presents significant challenges but also offers promising therapeutic avenues.
• Future research should focus on overcoming resistance and improving the efficacy of AKT-targeted therapies.